Cargando…

Assessing the Dynamics and Complexity of Disease Pathogenicity Using 4-Dimensional Immunological Data

Investigating disease pathogenesis and personalized prognostics are major biomedical needs. Because patients sharing the same diagnosis can experience different outcomes, such as survival or death, physicians need new personalized tools, including those that rapidly differentiate several inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivas, Ariel L., Hoogesteijn, Almira L., Antoniades, Athos, Tomazou, Marios, Buranda, Tione, Perkins, Douglas J., Fair, Jeanne M., Durvasula, Ravi, Fasina, Folorunso O., Tegos, George P., van Regenmortel, Marc H. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582751/
https://www.ncbi.nlm.nih.gov/pubmed/31249569
http://dx.doi.org/10.3389/fimmu.2019.01258
_version_ 1783428387694444544
author Rivas, Ariel L.
Hoogesteijn, Almira L.
Antoniades, Athos
Tomazou, Marios
Buranda, Tione
Perkins, Douglas J.
Fair, Jeanne M.
Durvasula, Ravi
Fasina, Folorunso O.
Tegos, George P.
van Regenmortel, Marc H. V.
author_facet Rivas, Ariel L.
Hoogesteijn, Almira L.
Antoniades, Athos
Tomazou, Marios
Buranda, Tione
Perkins, Douglas J.
Fair, Jeanne M.
Durvasula, Ravi
Fasina, Folorunso O.
Tegos, George P.
van Regenmortel, Marc H. V.
author_sort Rivas, Ariel L.
collection PubMed
description Investigating disease pathogenesis and personalized prognostics are major biomedical needs. Because patients sharing the same diagnosis can experience different outcomes, such as survival or death, physicians need new personalized tools, including those that rapidly differentiate several inflammatory phases. To address these topics, a pattern recognition-based method (PRM) that follows an inverse problem approach was designed to assess, in <10 min, eight concepts: synergy, pleiotropy, complexity, dynamics, ambiguity, circularity, personalized outcomes, and explanatory prognostics (pathogenesis). By creating thousands of secondary combinations derived from blood leukocyte data, the PRM measures synergic, pleiotropic, complex and dynamic data interactions, which provide personalized prognostics while some undesirable features—such as false results and the ambiguity associated with data circularity-are prevented. Here, this method is compared to Principal Component Analysis (PCA) and evaluated with data collected from hantavirus-infected humans and birds that appeared to be healthy. When human data were examined, the PRM predicted 96.9 % of all surviving patients while PCA did not distinguish outcomes. Demonstrating applications in personalized prognosis, eight PRM data structures sufficed to identify all but one of the survivors. Dynamic data patterns also distinguished survivors from non-survivors, as well as one subset of non-survivors, which exhibited chronic inflammation. When the PRM explored avian data, it differentiated immune profiles consistent with no, early, or late inflammation. Yet, PCA did not recognize patterns in avian data. Findings support the notion that immune responses, while variable, are rather deterministic: a low number of complex and dynamic data combinations may be enough to, rapidly, unmask conditions that are neither directly observable nor reliably forecasted.
format Online
Article
Text
id pubmed-6582751
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65827512019-06-27 Assessing the Dynamics and Complexity of Disease Pathogenicity Using 4-Dimensional Immunological Data Rivas, Ariel L. Hoogesteijn, Almira L. Antoniades, Athos Tomazou, Marios Buranda, Tione Perkins, Douglas J. Fair, Jeanne M. Durvasula, Ravi Fasina, Folorunso O. Tegos, George P. van Regenmortel, Marc H. V. Front Immunol Immunology Investigating disease pathogenesis and personalized prognostics are major biomedical needs. Because patients sharing the same diagnosis can experience different outcomes, such as survival or death, physicians need new personalized tools, including those that rapidly differentiate several inflammatory phases. To address these topics, a pattern recognition-based method (PRM) that follows an inverse problem approach was designed to assess, in <10 min, eight concepts: synergy, pleiotropy, complexity, dynamics, ambiguity, circularity, personalized outcomes, and explanatory prognostics (pathogenesis). By creating thousands of secondary combinations derived from blood leukocyte data, the PRM measures synergic, pleiotropic, complex and dynamic data interactions, which provide personalized prognostics while some undesirable features—such as false results and the ambiguity associated with data circularity-are prevented. Here, this method is compared to Principal Component Analysis (PCA) and evaluated with data collected from hantavirus-infected humans and birds that appeared to be healthy. When human data were examined, the PRM predicted 96.9 % of all surviving patients while PCA did not distinguish outcomes. Demonstrating applications in personalized prognosis, eight PRM data structures sufficed to identify all but one of the survivors. Dynamic data patterns also distinguished survivors from non-survivors, as well as one subset of non-survivors, which exhibited chronic inflammation. When the PRM explored avian data, it differentiated immune profiles consistent with no, early, or late inflammation. Yet, PCA did not recognize patterns in avian data. Findings support the notion that immune responses, while variable, are rather deterministic: a low number of complex and dynamic data combinations may be enough to, rapidly, unmask conditions that are neither directly observable nor reliably forecasted. Frontiers Media S.A. 2019-06-12 /pmc/articles/PMC6582751/ /pubmed/31249569 http://dx.doi.org/10.3389/fimmu.2019.01258 Text en Copyright © 2019 Rivas, Hoogesteijn, Antoniades, Tomazou, Buranda, Perkins, Fair, Durvasula, Fasina, Tegos and van Regenmortel. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Rivas, Ariel L.
Hoogesteijn, Almira L.
Antoniades, Athos
Tomazou, Marios
Buranda, Tione
Perkins, Douglas J.
Fair, Jeanne M.
Durvasula, Ravi
Fasina, Folorunso O.
Tegos, George P.
van Regenmortel, Marc H. V.
Assessing the Dynamics and Complexity of Disease Pathogenicity Using 4-Dimensional Immunological Data
title Assessing the Dynamics and Complexity of Disease Pathogenicity Using 4-Dimensional Immunological Data
title_full Assessing the Dynamics and Complexity of Disease Pathogenicity Using 4-Dimensional Immunological Data
title_fullStr Assessing the Dynamics and Complexity of Disease Pathogenicity Using 4-Dimensional Immunological Data
title_full_unstemmed Assessing the Dynamics and Complexity of Disease Pathogenicity Using 4-Dimensional Immunological Data
title_short Assessing the Dynamics and Complexity of Disease Pathogenicity Using 4-Dimensional Immunological Data
title_sort assessing the dynamics and complexity of disease pathogenicity using 4-dimensional immunological data
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582751/
https://www.ncbi.nlm.nih.gov/pubmed/31249569
http://dx.doi.org/10.3389/fimmu.2019.01258
work_keys_str_mv AT rivasariell assessingthedynamicsandcomplexityofdiseasepathogenicityusing4dimensionalimmunologicaldata
AT hoogesteijnalmiral assessingthedynamicsandcomplexityofdiseasepathogenicityusing4dimensionalimmunologicaldata
AT antoniadesathos assessingthedynamicsandcomplexityofdiseasepathogenicityusing4dimensionalimmunologicaldata
AT tomazoumarios assessingthedynamicsandcomplexityofdiseasepathogenicityusing4dimensionalimmunologicaldata
AT burandatione assessingthedynamicsandcomplexityofdiseasepathogenicityusing4dimensionalimmunologicaldata
AT perkinsdouglasj assessingthedynamicsandcomplexityofdiseasepathogenicityusing4dimensionalimmunologicaldata
AT fairjeannem assessingthedynamicsandcomplexityofdiseasepathogenicityusing4dimensionalimmunologicaldata
AT durvasularavi assessingthedynamicsandcomplexityofdiseasepathogenicityusing4dimensionalimmunologicaldata
AT fasinafolorunsoo assessingthedynamicsandcomplexityofdiseasepathogenicityusing4dimensionalimmunologicaldata
AT tegosgeorgep assessingthedynamicsandcomplexityofdiseasepathogenicityusing4dimensionalimmunologicaldata
AT vanregenmortelmarchv assessingthedynamicsandcomplexityofdiseasepathogenicityusing4dimensionalimmunologicaldata